Open AccessAntithymocyte Globulin Is Associated With a Lower Incidence of De Novo Donor-Specific Antibodies in Moderately Sensitized Renal Transplant Recipients
Author(s) -
Marissa M. Brokhof,
Hans W. Sollinger,
David Hager,
Brenda Muth,
John D. Pirsch,
Luis A. Fernández,
Janet Bellingham,
Joshua D. Mezrich,
David P. Foley,
Anthony M. D’Alessandro,
Jon S. Odorico,
Maha Mohamed,
Vijay Vidyasagar,
Thomas M. Ellis,
Dixon B. Kaufman,
Arjang Djamali
Publication year - 2014
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000000031
Subject(s) - basiliximab , medicine , immunosuppression , kidney transplantation , urology , gastroenterology , incidence (geometry) , plasmapheresis , population , transplantation , antibody , immunology , physics , environmental health , optics
Recent evidence suggests that de novo donor-specific antibodies (dnDSA) are associated with antibody-mediated rejection (ABMR) and graft failure after kidney transplantation. The effects of induction immunosuppression on dnDSA are unknown.